Skip to main content
OpenTrials
Completed

NCT Number: NCT04777240

Characterization of Enterococci

Study on Characterization of Enterococci because nowadays it become an important cause of nosocomial infections .detection of the most common two species of Enterococci and most common virulence factors & its genes with determination of antibiotics sensitivity test for the isolated strains

Completed

Looking for future studies?

Notify Me

Key information

Age range

2 month–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag Faculty of Medicine

Sohag, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • any patients in ICU has manifestations of urinary tract infections, surgical wound infections, intra-abdominal infections, intrapelvic infections, bacteraemia and infective endocarditis

Exclusion criteria

  • patients receiving antibiotics in previous 48 hours

Treatment and study plan

Primary outcomes

  1. I) Sample collection

    Time frame: 2 months

    Samples are collected from intensive care unit (ICU) including urine, pus swabs, sputum, blood, tracheal aspirates and pharyngeal swabs

  2. II) Identification of Enterococci:

    Time frame: 2 month

    by inoculation on Bile esculin azide & growing colonies further identified by :

    • microscopically after staining by gram stain
    • catalase test
    • grow on high concentration of NaCl (6.5%)
  3. III) Phenotypic detection of virulence marker of Enterococci(Gelatinase activity)

    Time frame: 2 weeks

    by culture on nutrient agar containing gelatin.Positive results appeared as liquefaction of gelatin

  4. IV)Phenotypic detection of virulence marker of Enterococci (hemolytic activity)

    Time frame: 1 week

    by Detection of hemolytic activity on the blood agar

  5. V) Phenotypic detection of virulence marker of Enterococci(Caseinase production)

    Time frame: 2 weeks

    by Detection of Caseinase production on Muller hinton agar containing skimmed milk 3%.

  6. VI) Phenotypic detection of virulence marker of Enterococci(Formation of Slime layer)

    Time frame: 1 week

    Formation of Slime layer by culture on Brain heart infusion agar containing 5% sucrose, plates are incubated for 24 hrs at 37oC. Positive strains gave mucoid and slimy colonies.

  7. VII) Phenotypic detection of virulence marker of EnterococcI (Biofilm formation)

    Time frame: 2 weeks

    using microtiter plate reader. Biofilm formation is scored as nonbiofilm forming (-), weak - (+), moderate - (++), and strong - (+++) corresponding to the A630 values ≤1, 1-≤2, 2-≤3, and>3, respectively

  8. VIII) Antibiotic sensitivity test:

    Time frame: 3 monthe

    • by 1- disc diffusion test using Vancomycin 30 μg, Teichoplanin 30 μg, Tetracycline 30 μg, Ampicillin 10 μg and Erythromycin 15 μg. Results ,Results are interpreted according to CLSI 2018.
    • E-test:

    MICs (minimal inhibitory concentrations) of Vancomycin are measured by E-test for confirmation of vancomycin resistance among the isolated Enterococci. Results are interpreted according to CLSI guidelines.

  9. IX) Molecular Identification of commonest Enterococcus species

    Time frame: 1 month

    by conventional gene specific uniplex PCR for E. faecalis and E. Faecium

  10. X) Molecular detection of virulence genes

    Time frame: 2 months

    Identification of virulence genes; gel E (gene for gelatinase), asa1 (gene for aggregation substance), cylA (gene for cytolysin activator), esp (gene for Enterococcal surface protein) Hyl (gene for Hyaluronidase) of E. faecalis and E. faecium was performed by uniplex PCR.The amplified products are visualized on 2% agarose gel stained with ethidium bromide. The stained gels are visualized and documented with a gel documentation system and analyzed visually to determine the size of PCR amplicons of the target genes directly by comparison with 100 bp DNA ladder marker.

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Characterization of Enterococci; Distribution of Virulence Markers, Virulence Genes and Antibiotic Resistance Pattern of the Isolated Species

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Mar 2, 2021
Registry last updated
Apr 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.